Total Payments
$16,843
2024 Payments
$1,093
Companies
74
Transactions
648
Medicare Patients
2,729
Medicare Billing
$662,084
Payment Breakdown by Category
Food & Beverage$12,956 (76.9%)
Education$1,615 (9.6%)
Consulting$1,272 (7.6%)
Other$1,000 (5.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,956 | 625 | 76.9% |
| Education | $1,615 | 21 | 9.6% |
| Consulting Fee | $1,272 | 1 | 7.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,000 | 1 | 5.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $2,128 | 50 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,127 | 46 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $1,092 | 7 | $0 (2022) |
| Janssen Biotech, Inc. | $738.93 | 35 | $0 (2023) |
| Celgene Corporation | $695.50 | 28 | $0 (2024) |
| Incyte Corporation | $661.63 | 19 | $0 (2023) |
| Daiichi Sankyo Inc. | $543.97 | 23 | $0 (2024) |
| Amgen Inc. | $513.43 | 19 | $0 (2023) |
| Seagen Inc. | $500.00 | 19 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $477.24 | 23 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,093 | 53 | Daiichi Sankyo Inc. ($173.21) |
| 2023 | $1,139 | 47 | Gilead Sciences, Inc. ($117.26) |
| 2022 | $3,706 | 150 | AstraZeneca Pharmaceuticals LP ($296.03) |
| 2021 | $2,741 | 120 | Janssen Biotech, Inc. ($233.02) |
| 2020 | $4,957 | 138 | E.R. Squibb & Sons, L.L.C. ($1,385) |
| 2019 | $2,823 | 122 | Celgene Corporation ($356.60) |
| 2018 | $127.78 | 3 | Amgen Inc. ($99.00) |
| 2017 | $257.12 | 15 | Janssen Biotech, Inc. ($91.47) |
All Payment Transactions
648 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $18.01 | General |
| 12/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | SOBI, INC | DOPTELET (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/03/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Oncology | ||||||
| 11/15/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $0.19 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $0.32 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Oncology | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $17.63 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Oncology | ||||||
| 10/09/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Oncology | ||||||
| 09/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.17 | General |
| 09/13/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $18.63 | General |
| Category: Oncology | ||||||
| 09/11/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 603 | 1,026 | $193,210 | $68,986 |
| 2022 | 15 | 710 | 8,269 | $365,721 | $165,535 |
| 2021 | 14 | 636 | 24,267 | $328,898 | $148,692 |
| 2020 | 17 | 780 | 46,239 | $763,732 | $278,870 |
Total Patients
2,729
Total Services
79,801
Medicare Billing
$662,084
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 252 | $58,591 | $25,016 | 42.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 110 | 110 | $52,786 | $19,435 | 36.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 66 | 73 | $31,174 | $10,103 | 32.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 14 | 41 | $14,350 | $4,445 | 31.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 34 | $5,118 | $2,241 | 43.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 13 | 70 | $5,250 | $1,622 | 30.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $3,385 | $1,410 | 41.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 29 | $4,785 | $1,324 | 27.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 77 | 143 | $2,860 | $1,193 | 41.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 77 | 141 | $8,460 | $1,065 | 12.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 59 | $2,950 | $643.53 | 21.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 11 | 36 | $3,420 | $466.89 | 13.7% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 13 | 27 | $81.00 | $21.84 | 27.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 16 | 4,740 | $137,460 | $81,571 | 59.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 153 | 351 | $56,160 | $35,035 | 62.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 18 | 138 | $48,300 | $16,226 | 33.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 35 | 35 | $15,400 | $6,094 | 39.6% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 18 | 211 | $15,825 | $5,492 | 34.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 29 | 31 | $14,570 | $4,999 | 34.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 153 | 492 | $29,520 | $3,755 | 12.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 19 | 57 | $9,405 | $3,263 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 18 | $4,950 | $2,740 | 55.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 35 | 146 | $7,300 | $1,775 | 24.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 13 | 26 | $4,160 | $1,737 | 41.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 153 | 491 | $9,820 | $1,445 | 14.7% |
About Dr. Joseph Tropea, DO
Dr. Joseph Tropea, DO is a Hematology & Oncology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013028729.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Tropea, DO has received a total of $16,843 in payments from pharmaceutical and medical device companies, with $1,093 received in 2024. These payments were reported across 648 transactions from 74 companies. The most common payment nature is "Food and Beverage" ($12,956).
As a Medicare-enrolled provider, Tropea has provided services to 2,729 Medicare beneficiaries, totaling 79,801 services with total Medicare billing of $662,084. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Philadelphia, PA
- Active Since 08/31/2006
- Last Updated 03/24/2015
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1013028729
Products in Payments
- OPDIVO (Biological) $1,822
- Tavalisse (Drug) $1,092
- XARELTO (Drug) $477.24
- KEYTRUDA (Biological) $393.37
- LIBTAYO (Biological) $359.85
- VENCLEXTA (Drug) $353.93
- JAKAFI (Drug) $302.43
- JEVTANA (Drug) $281.72
- LYNPARZA (Drug) $281.50
- ERLEADA (Drug) $281.32
- Revlimid (Drug) $252.52
- XPOVIO (Drug) $235.23
- AYVAKIT (Drug) $227.57
- INJECTAFER (Drug) $226.67
- Xermelo (Drug) $219.62
- Lenvima (Drug) $218.92
- Trodelvy (Drug) $215.95
- Enhertu (Drug) $210.60
- IMBRUVICA (Drug) $196.68
- Stivarga (Drug) $192.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Philadelphia
Shayma Kazmi, Md, MD
Hematology & Oncology — Payments: $715,210
Hematology & Oncology $715,210
Charu Aggarwal, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $510,275
Hematology & Oncology $510,275
Dr. Catherine Lai, M.d., M.p.h, M.D., M.P.H
Hematology & Oncology — Payments: $249,951
Hematology & Oncology $249,951
Dr. Martin Edelman, M.d, M.D
Hematology & Oncology — Payments: $207,464
Hematology & Oncology $207,464
Keith Pratz, M.d, M.D
Hematology & Oncology — Payments: $175,955
Hematology & Oncology $175,955
David Porter, Md, MD
Hematology & Oncology — Payments: $173,636
Hematology & Oncology $173,636